Showing 661 - 680 results of 1,008 for search '(( 13 1 decrease ) OR ( 10 ((we decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.16s Refine Results
  1. 661
  2. 662
  3. 663
  4. 664
  5. 665
  6. 666
  7. 667
  8. 668
  9. 669
  10. 670
  11. 671
  12. 672
  13. 673
  14. 674
  15. 675
  16. 676

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…Conversely, patients with non-heart failure-related polypharmacy had increased risks of ICU admissions (aOR=1.78, 95% CI: 1.13 – 2.70). ConclusionIn an examination of a database of patients with chronic heart failure, major non-heart failure-related polypharmacy was associated with increased risks in intensive care admissions. …”
    Get full text
    Get full text
    Get full text
  17. 677
  18. 678
  19. 679
  20. 680